Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the...

Markin P. A., Brito O. A. A., Moskaleva N. E., Lartsova E. V., Shpot Y. V., Lerner Yu. V., Mikhajlov V. Y., Potoldy'kova N. V., Enikeev D. V., La F. M. R., Appolonova S. A.
Metabolomics
Vol.16, Issue7, Num.74
Опубликовано: 2020
Тип ресурса: Статья

DOI:10.1007/s11306-020-01694-y

Аннотация:
Introduction: The metabolic alterations reflecting the influence of prostate cancer cells can be captured through metabolomic profiling. Objective: To characterize the plasma metabolomic profile in prostatic intraepithelial neoplasia (PIN) and prostate cancer (PCa). Methods: Metabolomics analyses were performed in plasma samples from individuals classified as non-cancerous control (n = 36), with PIN (n = 16), or PCa (n = 27). Untargeted [26 moieties identified after pre-processing by gas chromatography/mass spectrometry (GC/MS)] and targeted [46 amino acids, carbohydrates, organic acids and fatty acids by GC/MS, and 16 nucleosides and amino acids by ultra performance liquid chromatography-triple quadrupole/mass spectrometry (UPLC-TQ/MS)] analyses were performed. Prostate specific antigen (PSA) concentrations were measured in all samples. In PCa patients, the Gleason scores were determined. Results: The metabolites that were best discriminated (p < 0.05, FDR < 0.2) for the Kruskal–Walli
Ключевые слова:
Gas chromatography/mass spectrometry; Metabolome; Metabolomics; Prostate cancer; Ultra performance liquid chromatography-triple quadrupole/mass spectrometry
prostate specific antigen; adenocarcinoma in situ; amino acid composition; amino acid metabolism; Article; disease activity; Gleason score; high performance liquid chromatography; hormone synthesis; human; lipid metabolism; liquid chromatography-mass spectrometry; mass fragmentography; mass spectrometry; metabolic fingerprinting; metabolomics; principal component analysis; prostate cancer; receiver operating characteristic; sensitivity and specificity; ultra performance liquid chromatography
Язык текста: Английский
ISSN: 1573-3890
Markin P. A. Pavel Aleksandrovich 1996-
Brito O. A. A. Olivares Aleks Al`berto 1982-
Moskaleva N. E. Natal`ya Evgenyevna 1971-
Lartsova E. V. Ekaterina Viktorovna 1985-
Shpot Y. V.
Lerner Yu. V. Yuliya Vladimirovna 1981-
Mikhajlov V. Y.
Potoldy'kova N. V. Natal`ya Valerievna 1982-
Enikeev D. V. Dmitrij Viktorovich 1982-
La F. M. R. Frano M.R.
Appolonova S. A. Svetlana Aleksandrovna 1973-
Маркин П. А. Павел Александрович 1996-
Брито О. А. А. Оливарес Алекс Альберто 1982-
Москалева Н. Е. Наталья Евгеньевна 1971-
Ларцова Е. В. Екатерина Викторовна 1985-
Шпот Y. В.
Лернер Ю. В. Юлия Владимировна 1981-
Михайлов В. Y.
Потолдыкова Н. В. Наталья Валериевна 1982-
Еникеев Д. В. Дмитрий Викторович 1982-
Ла Ф. М. Р. Франо М.Р.
Апполонова С. А. Светлана Александровна 1973-
Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score
Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the...
Текст визуальный непосредственный
Metabolomics
Springer Science+Business Media Inc., Formerly Kluwer Boston Inc
Vol.16, Issue7 Num.74
2020
Статья
Gas chromatography/mass spectrometry Metabolome Metabolomics Prostate cancer Ultra performance liquid chromatography-triple quadrupole/mass spectrometry
prostate specific antigen adenocarcinoma in situ amino acid composition amino acid metabolism Article disease activity Gleason score high performance liquid chromatography hormone synthesis human lipid metabolism liquid chromatography-mass spectrometry mass fragmentography mass spectrometry metabolic fingerprinting metabolomics principal component analysis prostate cancer receiver operating characteristic sensitivity and specificity ultra performance liquid chromatography
Introduction: The metabolic alterations reflecting the influence of prostate cancer cells can be captured through metabolomic profiling. Objective: To characterize the plasma metabolomic profile in prostatic intraepithelial neoplasia (PIN) and prostate cancer (PCa). Methods: Metabolomics analyses were performed in plasma samples from individuals classified as non-cancerous control (n = 36), with PIN (n = 16), or PCa (n = 27). Untargeted [26 moieties identified after pre-processing by gas chromatography/mass spectrometry (GC/MS)] and targeted [46 amino acids, carbohydrates, organic acids and fatty acids by GC/MS, and 16 nucleosides and amino acids by ultra performance liquid chromatography-triple quadrupole/mass spectrometry (UPLC-TQ/MS)] analyses were performed. Prostate specific antigen (PSA) concentrations were measured in all samples. In PCa patients, the Gleason scores were determined. Results: The metabolites that were best discriminated (p < 0.05, FDR < 0.2) for the Kruskal–Walli